Clinical trial · Interventional
MRI in Ovarian Tumors
Role of Multi Paramertic MRI and MRI Perfusion in Indetermint Ovarian Lesions by Using ORADS MRI
NCT05769205CI-TRIAL-00064719unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Role of multi paramrtric MRI and MRI perfusion in indetermint ovarian lesions by using ORADS MRI
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Neoplasms | Ovarian Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MRI | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- female with ovarian masses
- description
- MRI with contrast according to the kidney function test of the patients
- interventionNames
- Device: MRI
Primary outcomes (1)
- measure
- MRI in ovarian tumors
- timeFrame
- 2 years
- description
- Role of parametric MRI in determint ovarian lesions by using ORADS MRI
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: females with ovarian masses \- Exclusion Criteria: * females with known benign ovarian masses
References
Publications (1)
- BACKGROUNDPatel RK, Garg A, Dixit R, Gandhi G, Khurana N. The role of "penumbra sign" and diffusion-weighted imaging in adnexal masses: do they provide a clue in differentiating tubo-ovarian abscess from ovarian malignancy? Pol J Radiol. 2021 Dec 15;86:e661-e671. doi: 10.5114/pjr.2021.111986. eCollection 2021. PMID 35059059